Get the Stockscreener App
2.58
9.79%
-0.28
After Hours:
2.44
-0.14
-5.43%
Adagio Medical Holdings Inc stock is traded at $2.58, with a volume of 38,642.
It is down -9.79% in the last 24 hours and down -49.90% over the past month.
Adagio Medical Holdings Inc is an innovator in catheter ablation technologies for treatment of cardiac arrhythmias. The company focuses on developing innovative cryoablation technologies that create contiguous, transmural lesions to treat cardiac arrhythmias, including paroxysmal and persistent atrial fibrillation, atrial flutter, and ventricular tachycardia.
See More
Previous Close:
$2.86
Open:
$3.155
24h Volume:
38,642
Relative Volume:
1.81
Market Cap:
$35.74M
Revenue:
-
Net Income/Loss:
-
P/E Ratio:
-
EPS:
-
Net Cash Flow:
-
1W Performance:
-26.70%
1M Performance:
-49.90%
6M Performance:
+0.00%
1Y Performance:
+0.00%
1-Day Range:
$2.44
$3.155
1-Week Range:
$2.44
$3.70
52-Week Range:
$2.44
$6.78
Adagio Medical Holdings Inc Stock (ADGM) Company Profile
Name
Adagio Medical Holdings Inc
Sector
Industry
Phone
212-284-2300
Address
26051 MERIT CIRCLE, LAGUNA HILLS
Adagio Medical Holdings Inc Stock (ADGM) Latest News
ADGM stock touches 52-week low at $3.51 amid market challenges - Investing.com Australia
ADGM stock touches 52-week low at $3.51 amid market challenges - Investing.com Canada
ADGM stock touches 52-week low at $3.51 amid market challenges - Investing.com India
ADGM stock touches 52-week low at $3.51 amid market challenges - Investing.com
ADGM stock touches 52-week low at $3.51 amid market challenges - Investing.com UK
Why Intel Shares Are Trading Higher By Around 7%; Here Are 20 Stocks Moving Premarket - Benzinga
Adagio Medical Holdings (NASDAQ:ADGM) Stock Quotes, Forecast and News Summary - Benzinga
Adagio Medical launches VT ablation system in Europe - Investing.com India
Adagio Medical launches VT ablation system in Europe - Investing.com
Adagio Medical Provides Business Updates - StockTitan
A proxy fight and large sale of Wendy’s shares - II Research
Adagio and ARYA IV combine to form new company focused on cardiac arrhythmia therapies - Cardiac Rhythm News
Adagio Medical goes public in SPAC merger - Mass Device
Reed Smith advises Adagio Medical on closing of business combination with ARYA Sciences Acquisition Corp IV - Reed Smith LLP
Mizuho posts 17.9% Q1 earnings increase, bolstered by Japan's end to deflation - Marketscreener.com
Owens & Minor to acquire Rotech Healthcare for nearly $1.4B - Mass Device
NASDAQ – Stock Price, Charts & News Today - BNN Bloomberg
ARYA Sciences IV Adds Another Month to Work on Adagio Deal - DealFlow's SPAC News
ARYA IV Updates Investor Presentation on Adagio Deal - DealFlow's SPAC News
Adagio Medical Announces CE Mark approval of VT Cryoablation System, Plans for Immediate Commercialization in Select European Centers - PR Newswire
Reed Smith’s Cheng, Cue named among top lawyers for DeSPAC transactions - Reed Smith LLP
Adagio speeds up financing rhythm with $42M SPAC deal - BioWorld Online
Pulsed Field Ablation (PFA) Market Braces for Surge Beyond US$ 11.7 Million by 2033 - PharmiWeb.com
Adagio Medical Combining with ARYA Sciences IV in $113M Deal - DealFlow's SPAC News
Assure Buys Danam Health To Form $150M Business - Law360
Pulsed Field Ablation Market to Record an Exponential CAGR by 2031Exclusive Report by InsightAce Analytic - Yahoo Finance
AGEDB Inc. Announces Definitive Agreement to be Acquired by Adagio Capital Inc. - PR Newswire
Adagio Medical Announces Initiation and First Procedure in FULCRUM-VT Trial, Starting The Process For Bringing Ultra-Low Temperature Cryoablation for Ventricular Arrhythmias to US Market - PR Newswire
Reed Smith represents Spectral MD on close of business combination with Rosecliff Acquisition Corp I - Reed Smith LLP
Reed Smith represents CorpAcq on business combination with Churchill Capital Corp VII - Reed Smith LLP
Adagio Medical Announces Completion of Enrollment in Cryocure-VT Trial, Maps the Pathway to CE-Mark of vCLAS™ VT Ablation Catheter - PR Newswire
Reed Smith advises Spectral MD Holdings on merger with Rosecliff Acquisition Corp - Reed Smith LLP
Adagio Medical Announces Initiation and First Patient Enrollment in PARALELL Trial To Investigate Safety and Performance of CryoPulse™ Catheter System for Pulsed Field Ablation and Pulsed Field Cryoablation of Persistent Atrial Fibrillation - BioSpace
New advisory group aims to improve pregnancy, postpartum care in Pa. | Five for the Weekend - Pennsylvania Capital-Star
Reed Smith advises Curtiss-Wright on the sale of Phönix Group to Liberta Partners - Reed Smith LLP
Adagio Medical Announces Successful First-In-Human Cases of Pulsed Field Cryoablation for Treatment of Atrial Fibrillation - PR Newswire
Top 5 IPOs of 2021 - Investopedia
Adagio Therapeutics Announces New Data Highlighting the Potential of ADG20 for Treatment and Prevention of COVID-19 - Yahoo Finance
Adagio Medical Raises $42.5 Million In Series E Financing - PR Newswire
Top Performing Stocks - Benzinga
Premarket Movers & News - Benzinga
Reed Smith represents Ali JK Nutritional Products Holding Limited on its sale of 100% equity interest in Ali JK ZNS Limited to Alibaba Health - Reed Smith LLP
Reed Smith Awarded Deal of the Year 2020 Asia-Pacific by The Banker for China Singyes Solar Restructuring project - Reed Smith LLP
BioWorld MedTech Patent Highlights: Week 6 - BioWorld Online
Best Stocks Under $10 • Charts Updated Daily - Benzinga
Medtronic’s dominance in cryoablation may be coming to an end - Medical Device Network
National Western Life Insurance Co Stock Price Today | NASDAQ: NWLI Live - Investing.com
Schellhorn out, Emerson in as Monteris CEO | Personnel Moves July 25, 2016Page 6 of 8 - Mass Device
Greatbatch rebrands as Integer Holdings - Mass Device
Cantel Medical pays $80m for UK ‘scope storage maker Medical Innovations - Mass Device
What medtech companies is BlackRock buying into? - Mass Device
Adagio Medical Holdings Inc Stock (ADGM) Financials Data
There is no financial data for Adagio Medical Holdings Inc (ADGM). Check out other stocks for more information.
Revenue
Net Income
Cash Flow
EPS
0.25%
1.46%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):